This video was published 173 Days 13 Hours 47 Mins ago.
Premium Access: Available NOW Member Access: Available NOW Public Access: Available NOW
THE 3 MINUTE PRESS SHOW with Tracee Tolentino
Discover the News behind the News from today's leading executives. Each day we interview the leading Executives on the press of that day.
The 3 Minute Press Show gives you the:
Who, What, Where, When, Why and How of this Press and how it will impact the company and its shareholders.
Members are encouraged to ask these executives questions through their message boards at Mywallst
Lantis was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. Lantis is currently entering Phase 3 development, moving through beta systems, product development and application for FDA clearance and plans to launch the OCT Dental Imaging System(tm) in the first quarter of 2009. Lantis has exclusive rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory (exclusive); Lightlab Imaging (non-exclusive) and AXSUN (exclusive). To find out more about Lantis Laser visit http://www.lantislaser.com.
GeneThera, Inc., a development stage biotechnology company, develops molecular assays for the detection of food contaminating pathogens, veterinary diseases, and genetically modified organisms. The co...
Avasant is recognized as one of the "Top-Ten" strategic sourcing advisory
firms by the Black Book of Outsourcing. Avasant helps clients navigate the
complete lifecycle for sourcing IT, Business and...
Featured Company:
